Early research (Phase 1)Study completedNCT00113347
What this trial is testing
Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 10